Curaleaf Holdings (CURLF) Net Income Growth (3y) (2022 - 2026)
Curaleaf Holdings (CURLF) Net Income Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 14.04% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.09% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 14.78% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Curaleaf Holdings | 2.61 Bn | 2.52 Bn | 169.91 Mn | 9.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.07% |
| Mar 31, 2026 | 71.45% |
| Dec 31, 2025 | -27.19% |
| Sep 30, 2025 | -26.30% |
| Jun 30, 2025 | 61.81% |
| Mar 31, 2025 | -39.26% |
| Dec 31, 2024 | 56.31% |
| Sep 30, 2024 | 26.60% |
| Jun 30, 2024 | 67.71% |
| Mar 31, 2024 | -66.30% |
| Dec 31, 2023 | -539.74% |
| Sep 30, 2023 | -42.63% |
| Jun 30, 2023 | 37.73% |
| Mar 31, 2023 | -41.19% |
| Dec 31, 2022 | 64.10% |
| Sep 30, 2022 | 258.61% |